Skip to main content
. 2017 Mar 8;8(22):35558–35572. doi: 10.18632/oncotarget.16009

Figure 7. The effects of meloxicam treatment on mRNA and protein expression levels of COX2 in the hippocampus of CUMS rats.

Figure 7

a. Changes in the mRNA expression of COX2 in the hippocampus of CUMS rats after treatment with meloxicam (1 and 3mg/kg, i.g.) or sertraline(5mg/kg, i.g.). b. The protein levels of COX2 in the hippocampus of CUMS rats after treatment with meloxicam (1 and 3mg/kg, i.g.) or sertraline(5mg/kg, i.g.). Each value represents the mean ± SD using a one-way ANOVA with a Bonferroni correction. **P < 0.01 vs control group. # and ## P < 0.05 and < 0.01 vs the CUMS group. n = 10.

HHS Vulnerability Disclosure